Hsbc Holdings PLC Buys 6,921 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Hsbc Holdings PLC increased its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 29.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,502 shares of the company’s stock after buying an additional 6,921 shares during the quarter. Hsbc Holdings PLC’s holdings in Pediatrix Medical Group were worth $227,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. ProShare Advisors LLC grew its stake in Pediatrix Medical Group by 7.4% in the 1st quarter. ProShare Advisors LLC now owns 16,937 shares of the company’s stock valued at $170,000 after purchasing an additional 1,167 shares during the period. Nisa Investment Advisors LLC grew its position in Pediatrix Medical Group by 47.2% during the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock valued at $36,000 after buying an additional 1,524 shares during the period. SummerHaven Investment Management LLC grew its position in Pediatrix Medical Group by 3.8% during the second quarter. SummerHaven Investment Management LLC now owns 55,951 shares of the company’s stock valued at $422,000 after buying an additional 2,069 shares during the period. Oppenheimer Asset Management Inc. increased its holdings in Pediatrix Medical Group by 4.5% during the first quarter. Oppenheimer Asset Management Inc. now owns 72,767 shares of the company’s stock worth $730,000 after buying an additional 3,142 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in Pediatrix Medical Group by 4.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 87,369 shares of the company’s stock worth $877,000 after acquiring an additional 3,669 shares during the period. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Price Performance

Pediatrix Medical Group stock opened at $12.13 on Friday. The firm has a market capitalization of $1.02 billion, a P/E ratio of -14.27, a PEG ratio of 1.74 and a beta of 1.56. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $13.01. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.38 and a quick ratio of 1.38. The business has a fifty day moving average price of $10.37 and a 200-day moving average price of $8.96.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Tuesday, August 6th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.31 by $0.03. Pediatrix Medical Group had a positive return on equity of 10.59% and a negative net margin of 12.58%. The business had revenue of $504.30 million during the quarter, compared to the consensus estimate of $505.49 million. During the same quarter last year, the company earned $0.37 EPS. The firm’s revenue was up .7% compared to the same quarter last year. As a group, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.19 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the stock. Truist Financial increased their target price on shares of Pediatrix Medical Group from $8.00 to $10.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. StockNews.com raised Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. Jefferies Financial Group upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating and boosted their target price for the company from $8.00 to $14.00 in a research note on Thursday, September 26th. UBS Group increased their price target on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a research note on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 price objective on the stock in a research note on Friday, June 7th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $10.30.

Insider Activity at Pediatrix Medical Group

In other Pediatrix Medical Group news, CEO James D. Swift sold 11,100 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $10.79, for a total value of $119,769.00. Following the sale, the chief executive officer now directly owns 170,001 shares in the company, valued at $1,834,310.79. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CFO C Marc Richards sold 17,438 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $10.08, for a total value of $175,775.04. Following the transaction, the chief financial officer now directly owns 175,347 shares in the company, valued at approximately $1,767,497.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO James D. Swift sold 11,100 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $10.79, for a total transaction of $119,769.00. Following the completion of the sale, the chief executive officer now directly owns 170,001 shares in the company, valued at $1,834,310.79. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 68,100 shares of company stock valued at $701,889. Corporate insiders own 2.00% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.